J&J corrects Impella controller over issue linked to 2 injuries, 1 death

J&J corrects Impella controller over issue linked to 2 injuries, 1 death is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-05-26

The controller can stop for about 35 seconds, during which time the patient is unsupported by the heart pump.

Source: MedTech Dive